---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-050390"
form_type: "8-K"
ticker: "PSTV"
cik: "0001095981"
company_name: "PLUS THERAPEUTICS, INC."
filed_at: "2025-03-10T23:59:59+00:00"
generated_at: "2026-05-25T00:48:49.465918+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Plus Therapeutics regains Nasdaq minimum equity compliance after private placement

## Summary
- Received Nasdaq letter dated March 7, 2025 confirming compliance with minimum stockholders' equity requirement (Rule 5550(b)(1)).
- Compliance achieved via private placement disclosed on March 4, 2025; escrow funds now released to the company.
- Subject to Mandatory Panel Monitor until March 7, 2026; any future non-compliance triggers immediate delisting without cure period.

## SEC filing metadata
- accession: 0001193125-25-050390
- form_type: 8-K
- ticker: PSTV
- cik: 0001095981
- company_name: PLUS THERAPEUTICS, INC.
- filed_at: 2025-03-10T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.7
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1095981/000119312525050390/0001193125-25-050390-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1095981/000119312525050390/d938890d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-050390
- JSON: https://secwatch.observer/filing/0001193125-25-050390.json
- Plain text: https://secwatch.observer/filing/0001193125-25-050390.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.